British American Tobacco plc isn’t the only FTSE 100 stock you might regret not buying

FTSE 100 (INDEXFTSE:UKX) giant British American Tobacco plc (LON:BATS) is expected to deliver strong growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Tobacco stocks have been profitable investments in recent years. British American Tobacco (LSE: BATS) has risen by more than 60% over the last five years, during which its dividend has risen by 29%.

However, growth isn’t the only reason to own tobacco stocks. Another key attraction is the defensive quality of these firms — their ability to provide stable returns even in tough times. This makes them a good hedge to the cyclical stocks in our portfolios, whose returns tend to be more variable.

In this article I’m going to catch up on the latest trading figures from BAT and consider the appeal of a cyclical FTSE 100 stock with an affordable valuation and a 5.4% yield.

Outperforming the industry?

BAT’s acquisition of Reynolds American earlier this year is another step in the firm’s mission to consolidate the industry, cut costs and boost profits even as global tobacco sales fall.

This plan seems to be working. Management expects industry-wide sales volumes to have fallen by 4% in 2017, but expects BAT sales to have fallen by less than this as it gains market share.

However, pricing power in markets such as Russia is said to have become “more difficult” this year. The company has also seen some customers trade down to cheaper brands following significant increases in excise duty in a number of Middle Eastern markets.

Despite this, profits are expected to be in line with expectations, helped by a 5% tailwind from favourable exchange rate movements.

Cheap enough to buy?

The shares have now fallen by around 10% from this summer’s peak of more than £55. In my view, this stock is starting to look more reasonably priced again.

Analysts expect earnings per share to rise by at least 10% this year, and in 2018. On this basis, I think the stock’s 2018 forecast P/E of 16.3 and prospective yield of 4% look reasonable. In my view, BAT remains a tempting choice for long-term income investors.

A discount I can’t ignore

A stock in my own portfolio is mining group Anglo American (LSE: AAL). I’ve held onto these shares and in fact have bought more this year, as the company’s performance has been better than expected.

Despite this, the firm’s shares still trade at a notable discount to its two main rivals, Rio Tinto and BHP Billiton. For example, Anglo’s business is valued at 1.2 times its book value, compared to 2 times for Rio and 1.7 times for BHP.

One reason for this is the political and operational risks faced by Anglo American’s operations in South Africa. Another consideration is that historically, this business has been less profitable than its rivals.

Despite this, I think Anglo’s discounted valuation is still too cheap to ignore. Net debt has halved since the end of 2015 and the group’s shares currently trade on just six times its trailing 12-month free cash flow. That’s much cheaper than the firm’s two big rivals.

Having turned around the business, I believe Anglo’s management will now be focused on demonstrating the value in its assets. I continue to rate the shares as a buy.

Roland Head owns shares of Anglo American. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »